Filing Details

Accession Number:
0001144204-16-115761
Form Type:
4
Zero Holdings:
No
Publication Time:
2016-08-01 20:28:13
Reporting Period:
2016-07-29
Filing Date:
2016-08-01
Accepted Time:
2016-08-01 20:28:13
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1037649 Interleukin Genetics Inc ILIU In Vitro & In Vivo Diagnostic Substances (2835) 943123681
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1339155 B Mark Carbeau C/O Interleukin Genetics, Inc.
135 Beaver Street
Waltham MA 02452
Chief Executive Officer Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2016-07-29 100,603 $0.10 100,603 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Common Stock Warrant (right to buy) Acquisiton 2016-07-29 100,603 $0.00 100,603 $0.10
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
100,603 2016-07-29 2023-07-29 No 4 P Direct